PODD News and Press, Insulet Corporation From 06/11/24

2024-06-11 16:27:23 ET Summary Insulet Corporation saw a significant drop in stock price in 2023 due to concerns over the impact of GLP-1 weight loss drugs on the insulin pump industry. These fears seem to be largely overblown, however, meaning that Insulet is arguably still tradi...

2024-06-10 10:15:02 ET OTR Global analyst issues MIXED recommendation for PODD on June 10, 2024 09:31AM ET. PODD was trading at $189 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 10 - Buy, 2 - Hold reco...

2024-06-06 06:19:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There is no such thing as safe gains in the market, at least in the near term. However, many stocks are very solid and won’t disappoint you in the long run. Wall Street often pays a prem...

2024-06-05 11:21:33 ET More on iShares U.S. Medical Devices ETF: IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF Don't expect pandemic backlog to fuel orthopedic sales, says Needham Seeking Alpha’s Quant Rating on iShares U....

2024-05-30 13:39:13 ET Read the full article on Seeking Alpha For further details see: Insulet, Tandem new buys from Redburn Atlantic in diabetes technology space

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that management will present at the Jefferies Global Healthcare Conference in New York City on Thursday, June 6, 2024 at 9:00 a.m....

2024-05-23 10:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-22 13:55:06 ET More on Establishment Labs, Edwards Lifesciences, etc. Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade) Nevro Corp. (NVRO) Q1 2024 Earnings ...

2024-05-19 14:08:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run. While most ...

2024-05-13 06:00:06 ET Matt Miksic from Barclays issued a price target of $200.00 for PODD on 2024-05-13 05:06:00. The adjusted price target was set to $200.00. At the time of the announcement, PODD was trading at $165.9. The overall price target consensus is at $293.15 ...